SELARL Respire
Haguenau, 67500, France
NCT Number: NCT04712825
The prevalence of chronic insomnia is 13.3% in France in 2019 (8.9 million). The consequences for these people are multiple: drowsiness, memory problems, difficulty concentrating, anxiety.
Cognitive and Behavioral Therapy (CBT) is today the reference treatment recommended by the "Haute Autorité de Santé" and the American College of Physicians for chronic insomnia. Today, however, few patients use CBT treatment due to the lack of trained practitioners, the cost of non-reimbursed sessions and the time and involvement that these sessions require.
Several clinical trials have shown beneficial effects of hypnotherapy on sleep disorders. The hypothesis of this work is that the use of hypnosis in virtual reality improves sleep time in patients suffering from insomnia disorders.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Haguenau, 67500, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cognitive-behavioural therapy sessions during 6 weeks of treatment
HypnoVR® sessions during 6 weeks of treatment
Time frame: after 6 weeks of treatment
Demonstrate a decrease in time to sleep after treatment, by polysomnography
HypnoVR
Industry
Effect of Medical Hypnosis in Virtual Reality on Insomnia Disorders: a Monocentric, Randomized, Open-label, Comparative Study.
Acronym: EMERITE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02967185
Dyssomnias, Insomnia Chronic
View Trial DetailsNCT04598672
Chronic Disease, Disease Attributes
Oslo, Norway
View Trial DetailsNCT05917379
Anxiety, Anxiety Disorders
Hefei, Anhui, China
View Trial DetailsNCT06550388
Dyssomnias, Insomnia Chronic
Jacksonville, Florida, United States
View Trial Details